Kura Oncology, Inc.

KURANasdaq· Pharmaceutical Preparations

Price History

Revenue

$67.5M

▲ 25.2% YoY

Net Income

-$278.7M

▼ 60.2% YoY

EPS

$-3.18

▼ 57.4% YoY

Cash

$149.1M

▼ 33.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.